TerrAscend Corp (TED) - Net Assets

Latest as of December 2025: €99.02 Million EUR ≈ $115.77 Million USD

Based on the latest financial reports, TerrAscend Corp (TED) has net assets worth €99.02 Million EUR (≈ $115.77 Million USD) as of December 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€557.38 Million ≈ $651.63 Million USD) and total liabilities (€458.36 Million ≈ $535.87 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check TerrAscend Corp tangible equity quality to evaluate the tangible quality of the company's equity base.

Key Net Assets Metrics

Metric Value
Current Net Assets €99.02 Million
% of Total Assets 17.77%
Annual Growth Rate 53.6%
5-Year Change -56.75%
10-Year Change N/A
Growth Volatility 1102.96

TerrAscend Corp - Net Assets Trend (2016–2025)

This chart illustrates how TerrAscend Corp's net assets have evolved over time, based on quarterly financial data. See how many days can TerrAscend Corp fund operations to measure how many days the company can operate on defensive assets alone.

Annual Net Assets for TerrAscend Corp (2016–2025)

The table below shows the annual net assets of TerrAscend Corp from 2016 to 2025. For live valuation and market cap data, see TerrAscend Corp (TED) market capitalisation.

Year Net Assets Change
2025-12-31 €99.02 Million
≈ $115.77 Million
-44.00%
2024-12-31 €176.82 Million
≈ $206.72 Million
-26.55%
2023-12-31 €240.74 Million
≈ $281.45 Million
-25.04%
2022-12-31 €321.17 Million
≈ $375.48 Million
+40.28%
2021-12-31 €228.95 Million
≈ $267.67 Million
+1959.49%
2020-12-31 €11.12 Million
≈ $13.00 Million
-85.24%
2019-12-31 €75.33 Million
≈ $88.07 Million
+30.10%
2018-12-31 €57.90 Million
≈ $67.69 Million
-14.05%
2017-12-31 €67.37 Million
≈ $78.76 Million
+3137.32%
2016-12-31 €2.08 Million
≈ $2.43 Million
--

Equity Component Analysis

This analysis shows how different components contribute to TerrAscend Corp's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have decreased by 86277618300.0% over the analyzed period, potentially due to dividend distributions or operating losses.

Current Equity Component Breakdown (December 2025)

Component Amount Percentage
Other Components €962.23 Million 987.05%
Total Equity €97.48 Million 100.00%

TerrAscend Corp Competitors by Market Cap

The table below lists competitors of TerrAscend Corp ranked by their market capitalization.

Company Market Cap
Tureks Turizm Tasimacilik AS
IS:TUREX
$197.63 Million
Wei Chuan Foods Corp
TW:1201
$197.70 Million
Shalby Limited
NSE:SHALBY
$197.73 Million
Global Water Resources Inc
NASDAQ:GWRS
$197.80 Million
Solid FAB
ST:SFAB
$197.53 Million
Huons Global Co. Ltd
KQ:084110
$197.40 Million
Gansu Mogao Industrial Development Co Ltd
SHG:600543
$197.36 Million
Atomera Inc
NASDAQ:ATOM
$197.35 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in TerrAscend Corp's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 176,960,000 to 97,485,000, a change of -79,475,000 (-44.9%).
  • Net loss of 86,228,000 reduced equity.
  • Share repurchases of 410,000 reduced equity.
  • Other factors increased equity by 7,163,000.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income €-86.23 Million -88.45%
Share Repurchases €410.00K -0.42%
Other Changes €7.16 Million +7.35%
Total Change €- -44.91%

Book Value vs Market Value Analysis

This analysis compares TerrAscend Corp's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 1.73x
  • The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
  • The price-to-book ratio has increased from 0.76x to 1.73x over the analyzed period, suggesting growing market confidence.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2017-12-31 €0.71 €0.55 x
2018-12-31 €0.74 €0.55 x
2019-12-31 €0.47 €0.55 x
2020-12-31 €0.01 €0.55 x
2021-12-31 €0.89 €0.55 x
2022-12-31 €1.24 €0.55 x
2023-12-31 €0.84 €0.55 x
2024-12-31 €0.61 €0.55 x
2025-12-31 €0.32 €0.55 x

Capital Efficiency Dashboard

This dashboard shows how efficiently TerrAscend Corp utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -88.45%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -33.09%
  • • Asset Turnover: 0.47x
  • • Equity Multiplier: 5.72x
  • Recent ROE (-88.45%) is above the historical average (-1375.00%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2016 -41.67% 0.00% 0.00x 1.86x €-1.08 Million
2017 -10.10% 0.00% 0.00x 1.03x €-13.54 Million
2018 -39.01% -322.71% 0.08x 1.58x €-27.68 Million
2019 -323.62% -254.26% 0.18x 6.91x €-222.46 Million
2020 -13068.49% -78.22% 0.33x 508.75x €-155.24 Million
2021 1.39% 1.48% 0.36x 2.60x €-19.25 Million
2022 -95.35% -122.65% 0.35x 2.20x €-335.84 Million
2023 -39.40% -38.14% 0.38x 2.75x €-119.79 Million
2024 -45.34% -29.93% 0.44x 3.43x €-97.93 Million
2025 -88.45% -33.09% 0.47x 5.72x €-95.98 Million

Industry Comparison

This section compares TerrAscend Corp's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

  • Industry: Drug Manufacturers - Specialty & Generic
  • Average net assets among peers: $6,888,924,775
  • Average return on equity (ROE) among peers: -44.00%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
TerrAscend Corp (TED) €99.02 Million -41.67% 4.63x $197.60 Million
SHANG.FOS.PHARM.GR.H YC 1 (08HH) $61.84 Billion 5.45% 0.94x $1.13 Billion
PEPTONIC MEDICAL (28L) $47.09 Million -78.27% 0.82x $4.14 Million
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited (2TZ) $6.55 Billion 13.15% 0.55x $692.11 Million
WEST ISLAND BRANDS INC. (39N0) $3.27 Million -157.21% 0.88x $1.34 Million
AYURCANN HOLDINGS CORP. (3ZQ0) $2.69 Million -197.11% 3.73x $97.35K
CERENO SCIENTIFIC AB B (4A1) $216.42 Million -22.23% 0.32x $157.72 Million
MAPLE LEAF GREEN WORLD (4HV0) $-9.91 Million 0.00% 0.00x $504.30K
LORDS CO. WORLDW. HOLD. (4XM) $-1.01 Million 0.00% 0.00x $134.78K
RED LIGHT HOLLAND CORP. (4YX) $17.35 Million -23.30% 0.22x $13.93 Million
EQL PHARMA AB (7JK) $221.03 Million 19.51% 2.66x $78.37 Million

About TerrAscend Corp

F:TED Germany Drug Manufacturers - Specialty & Generic
Market Cap
$197.60 Million
€169.02 Million EUR
Market Cap Rank
#16691 Global
#1580 in Germany
Share Price
€0.55
Change (1 day)
-1.80%
52-Week Range
€0.17 - €1.09
All Time High
€13.10
About

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States. The company manufactures vaporizables, concentrates, topicals, flowers, tinctures, and edibles. It offers its products under the brand name Kind Tree Cannabis, Legend, Valhalla Confections, State Flower Cannabis, Ilera Healthcare, Wana, and Cookies. The company also operates retail dispensaries und… Read more